Singapore · Biotechnology startup
Singapore · ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.
Funding reportedLast round: Post ipo equity
Follow ASLAN Pharmaceuticals and see its new rounds in your feed.Start following
What company datasets say ASLAN Pharmaceuticals raised
Funding, as reported
Reported in all186Min the source's currency
Rounds10
Last roundPost ipo equity
Last round dateMar 2024
Investors listed17
Biotechnology in Singapore
Startups like it
Is this your company?
Add your raise, your deck and your story, and put ASLAN Pharmaceuticals in front of investors. Or tell us what we have wrong.